- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Eli Lilly and Co.
Cornelius to retire as Bristol-Myers Squibb CEO
March 3, 2010
IBJ Staff and Associated PressThe former Guidant Corp. CEO and long-time Eli Lilly exec said he and his family will be returning to Indianapolis.
MoreTo attack costs, Lilly accelerates R&D
March 3, 2010
J.K. WallWith President Barack Obama looking to squeeze a bit more revenue out of the pharmaceutical industry, the stakes just keep
getting higher for Eli Lilly and Co.'s efforts to develop drugs faster and cheaper.
MoreLilly to shift more employees to Covance
February 26, 2010
J.K. WallGreenfield Labs operation expects to add 17 Eli Lilly and Co. workers after taking over staff of 264 in 2008 acquisition.
MoreObama health reform plan slaps drugmakers
February 24, 2010
J.K. WallDrugmakers, such as Indianapolis-based Eli Lilly and Co., would shoulder $3.3 billion in fees, face ban on pay-for-delay deals
with generic competitor.
MoreLilly, Merck, Pfizer starting research center
February 23, 2010
Associated PressThree major U.S. drugmakers said they have formed a not-for-profit company in Asia to focus on cancer research and treatments.
MoreWellPoint gets tax delay in Obama health plan
February 22, 2010
Bloomberg NewsInsurers WellPoint Inc. and others would get a delay in taxes on premiums and high-cost medical benefits, along with additional
funding for expanding Medicaid, under a White House proposal
MoreLilly asks shareholders to lower takeover barrier
February 20, 2010
J.K. WallEli Lilly and Co. directors have recommended that shareholders toss out the
drugmaker's most potent protection against unwanted takeovers: an 80-percent supermajority vote threshold for any shareholder
mutiny to succeed.
MoreTeva gets European OK to sell generic of Lilly's Evista
February 19, 2010
Bloomberg NewsEvista generated $1.03 billion in sales last year, of which $348.1 million came outside the United States.
MorePfizer's Viagra patent partially rejected in Lilly fight
February 16, 2010
Bloomberg NewsThe patent on impotence drug Viagra was partially rejected after the U.S. Patent and Trademark Office said it wasn't different
enough from a Chinese herb known as Horny Goat Weed. The patent was key to an infringement suit Pfizer filed in 2002 against
Eli Lilly and Co. over its rival Cialis drug.
MoreLilly awards pay increases to top executives
February 8, 2010
Peter Schnitzler, J.K. WallEli Lilly and Co. CEO John Lechleiter's total compensation increased $4.1 million in 2009.
MoreMississippi settles Zyprexa suit against Lilly for over $18M
February 4, 2010
Associated PressMississippi will receive $18.5 million from Indianapolis-based drugmaker Eli Lilly and Co. as part of a settlement over claims
the company promoted the anti-psychotic Zyprexa for ailments it was not federally approved to treat.
MoreQ&A: Dr. Kristine Courtney
February 3, 2010
J.K. WallDr. Kristine Courtney, Eli Lilly and Co.’s senior director of corporate health services, describes
how and why the company spent two years making its clinics some of the first to electronically swap patient records with
a local hospital database.
MoreLilly shares trade down after fourth-quarter profits falls
January 28, 2010
J.K. WallAnalysts worry about dive in already paltry sales of new blood thinner Effient
MoreLilly's profits fall, miss analyst expectations
January 28, 2010
J.K. WallThe Indianapolis-based drugmaker says a weaker dollar depressed earnings in the fourth quarter compared with a year ago.
MoreLilly looks to autoimmune drugs
January 27, 2010
J.K. WallTwo local researchers show why Eli Lilly and Co. and its peers are interested in developing medicines to treat automimmune
diseases: The costs of treating them are growing twice as fast as the prescription drug market.
MoreLilly shares get boost from OK of rival's drug
January 26, 2010
IBJ Staff and Bloomberg NewsShares of Lilly and partner Amylin rose on hopes that their new version of Byetta will be approved following U.S. regulators'
clearance of a similar drug.
MoreBiotech firm plans $28M Greenwood plant
January 19, 2010
Greenwood pharmaceutical firm Elona Biotechnologies plans to build a $28 million production facility and create 70 jobs to
help develop a cheaper form of insulin that could gain significant market share.
MoreFDA letters scold Lilly, others over marketing materials
January 13, 2010
Associated PressThe letter to Indianapolis-based Lilly cites a print advertisement for the antidepressant Cymbalta that did not adequately
display information about the drug's side effects.
MoreFDA cancels meeting to review Lilly's Cymbalta
January 5, 2010
Associated PressThe agency said the meeting was canceled "to allow time for the FDA to review new information" about a proposed new use for
the drug.
MoreRuth Lilly remembered for 'selfless' giving
December 31, 2009
Andrea Muirragui DavisLilly, 94, who died Wednesday, gave away hundreds of millions of dollars of her fortune during her lifetime.
MoreEli Lilly and Co. heiress Ruth Lilly dies at 94
December 31, 2009
Associated PressOver the course of her life, the last surviving great-grandchild of pharmaceutical magnate Eli Lilly gave away much of her
inheritance.
MoreCorporations bet on insiders to bend reform
December 30, 2009
J.K. WallIndianapolis health care heavyweights are among those spending $635 million, employing 166 former aides to key congressional
leaders and committees in health reform process.
MoreLilly scurries to get out from under Zyprexa cloud
December 26, 2009
J.K. WallAnother year of rapid change at Eli Lilly and Co. did little to move the company out from under the cloud cast by its best-selling
drug, Zyprexa.
MoreTo keep sales force busy, Lilly takes on new drug
December 24, 2009
J.K. WallEli Lilly and Co. has bought the rights to co-market a new cholesterol-fighting drug in the U.S., giving it a third heart
drug for sales personnel
to push.
MoreLilly pays $90 million for autoimmune drug
December 21, 2009
IBJ StaffBy acquiring an experimental medicine for rheumatoid arthritis, the Indianapolis-based drugmaker is increasing its focus on
autoimmune
diseases.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Ameriana Bank took over Westfield Farmers Market for 2013 and it is held in their parking lot, corner of 32 and Carey road, 5 to 8. I am selling soap and candles there. great market!
B&T certainly has enough of our taxpayer dollars to do this thanks to Mayor Ballard. Given the firm's exceedingly poor reputation in the legal community, the basement would seem a better option.
Should read MAY hire 20 people.
Not a good location for a 300,000 home. 10th Street fumes, buses, noise. Max for this location 150,000.
The state constitution also does not say that the majority has a right to quorum, nor that the minority is required to allow them quorum. In fact, denial of quorum has been a parliamentary maneuver since the establishment of the first parliaments in the early 1600s. The right to deny quorum (and the requirement fore quorum) are to prevent exactly what happened in Indiana: A tyrannical majority pushing through odious, objectionable legislation. Denial of quorum is totally legitimate, and lest we forget, a tactic the GOP has employed many, many times to ensure their issues weren't given short shrift. By allowing the majority to impose "fines" on the minority for exercising the authority the constitution grants them (to deny quorum,) they are violating the constitution.